WinstonWınston
Back
Bastide Le Confort Médical S.A. logo

Bastide Le Confort Médical S.A.

BLC.PA
44
Medical - Care Facilities · Healthcare
Also trades as: 0IP1.L
Price
€23.00
+0.30 (+1.32%)
Market Cap
€168.1M
Exchange
Euronext Paris
Winston Score
44
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Weak
Valuation
Good

Share count rising — dilution

+7.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 7.4M (2021) → 7.9M (2025)

Winston Score History

The full picture

Bastide Le Confort Médical is a French company that provides medical equipment and home healthcare services to patients who need ongoing care outside of a hospital. Its core services include supplying oxygen therapy, sleep apnea devices, wheelchairs, and other mobility or respiratory equipment directly to patients at home. The company works closely with doctors, hospitals, and French social security to deliver and maintain this equipment for people with chronic conditions.

Bastide earns revenue mainly through long-term service contracts and equipment rentals, with French public health insurance reimbursing a large share of costs. It operates almost entirely in France, with some presence in other European markets, and its established network of local service branches creates a barrier for new competitors to replicate quickly. The main risk the company faces is its heavy dependence on French government reimbursement rates, which regulators can reduce, directly squeezing the margins that are already thin at around 10 percent.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
10.9%
Thin — 10.9% gross margin
Profit after running costs
Operating Margin
9.0%
Modest — 9.0% operating margin
Return on the money invested
ROCE
11.5%
Below par — 11.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-11.9%
Shrinking sales (-11.9% YoY)
Profit growth
EPS YoY
>+1,000%
Earnings growing fast (>+1,000% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
268%
Turns 268% of profit into real cash
Spare cash per sale
FCF Margin
6.3%
Modest free cash flow (6.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.63
Heavy debt load (2.63)
Covers its interest
Interest Cover
1.53x
Dangerous — barely covers interest (1.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
5.8x
Attractive valuation — P/E 5.8

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
-7.6
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial